MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) Stock Information | RedChip

MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) Listen to this Section


$1.91
+0.0300 ( +1.60% ) 530.8K

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Market Data


Open


$1.91

Previous close


$1.88

Volume


530.8K

Market cap


$28.53M

Day range


$1.76 - $1.92

52 week range


$0.51 - $6.83

Insider Ownership Transactions

Total Amount Purchased: -1,090,367.00 | $ -2,082,600.97

Date Type Amount Purchased Purchaser
2024-06-21 Sale -50000.00 Shekhat Denil Nanji
2024-05-30 Sale -379000.00 Aminov Erez
2024-05-22 Buy 2000.00 Aminov Erez
2024-03-27 Sale -50000.00 Del Giudice Matthew Paul
2024-03-27 Sale -50000.00 MacPherson Edward Clouston
2024-03-27 Sale -150000.00 Yanez Michelle
2024-03-27 Sale -50000.00 Shekhat Denil Nanji
2024-03-27 Sale -300000.00 Aminov Erez
2024-03-27 Sale -50000.00 Jerman Michael Allen
2023-12-27 Sale -13367.00 McNulty Brian Patrick

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 50 Aug 13, 2024
8-k 8K-related 13 Aug 09, 2024
8-k 8K-related 13 Aug 08, 2024
def Proxies and info statements 3 Jul 26, 2024
8-k 8K-related 13 Jul 24, 2024
8-k 8K-related 13 Jul 19, 2024
8-k 8K-related 13 Jul 12, 2024
8-k 8K-related 14 Jun 28, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 May 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.